Acrotech Biopharma Inc.
Clinical trials sponsored by Acrotech Biopharma Inc., explained in plain language.
-
New combo therapy aims to outperform standard chemo for rare blood cancer
Disease control Recruiting nowThis phase 3 study tests whether adding either Beleodaq or Folotyn to standard chemotherapy (CHOP) helps people with newly diagnosed peripheral T-cell lymphoma live longer without their cancer getting worse. About 504 participants will be randomly assigned to one of three treatme…
Phase: PHASE3 • Sponsor: Acrotech Biopharma Inc. • Aim: Disease control
Last updated May 26, 2026 11:38 UTC
-
New study checks cancer drug safety in patients with liver issues
Knowledge-focused Recruiting nowThis study looks at how the drug pralatrexate is processed by the body in people with advanced solid tumors or blood cancers who also have mild, moderate, or severe liver problems. Researchers will measure drug levels in the blood and track side effects. The goal is to find the r…
Phase: PHASE1 • Sponsor: Acrotech Biopharma Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:34 UTC